01 1Cadila Pharmaceuticals
01 1CELECOXIB USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-21
Pay. Date : 2013-09-11
DMF Number : 19155
Submission : 2006-01-19
Status : Active
Type : II
20
Cadila Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CELECOXIB USP, with a corresponding US DMF Number 19155.
Remarkably, this DMF maintains an Active status since its submission on January 19, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 21, 2013, and payment made on September 11, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
